Work

1509MO Adherence to the Food and Drug Administration (FDA) guidance for the co-development of two or more investigational new drugs in phase 1/2 cancer trials

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.838

Authors: J.T. Moyers, D. Nguyen, D.S. Hong, E.E. Ileana Dumbrava, S. Fu, D. Karp, A. Naing, S. Pant, F. Janku, S.A. Piha-Paul, J. Rodon, V. Subbiah, A.M. Tsimberidou, F. Meric-Bernstam, T.A. Yap

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3204818527

FWCI:

Cites:

Cited by:

Related to: 10